Nasal polyposis: from cytokines to growth

Area of Science:

• Immunology
• Pathology
• Otorhinolaryngology

Background:

• Nasal polyposis (NP) is a chronic inflammatory condition characterized by eosinophil infiltration.
• The precise mechanisms linking eosinophilic inflammation to polyp formation are not fully understood.

Purpose of the Study:

• To investigate the histopathology of early-stage nasal polyps.
• To quantify inflammatory mediators and extracellular matrix components in nasal polyps.
• To explore the relationship between eosinophilic inflammation and polyp growth.

Main Methods:

• Histomorphologic analysis of early and mature nasal polyps.
• Measurement of cytokines (IL-5), chemokines (eotaxin), inflammatory proteins (ECP), leukotrienes, growth factors (TGF-beta 1), and matrix proteins (fibronectin, hyaluronic acid, albumin) in nasal tissue homogenates.
• Comparison between untreated polyps, polyp patients treated with oral glucocorticoids, and control subjects.

Main Results:

• Early polyps show eosinophils and albumin-filled pseudocysts; mature polyps have larger pseudocysts surrounded by eosinophilia.
• Untreated nasal polyps exhibit significantly higher IL-5, eotaxin, ECP, and albumin compared to controls.
• Oral glucocorticoid treatment significantly reduced ECP and albumin levels in polyps.

Conclusions:

• Albumin deposition and extracellular matrix changes, potentially regulated by subepithelial eosinophilic inflammation, are implicated in nasal polyp pathogenesis.
• IL-5 and eotaxin are critical for eosinophil accumulation and activation in NP.
• Oral glucocorticoids may reduce nasal polyp size by downregulating eosinophilic inflammation and albumin extravasation.